Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/6838
Title: | Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study | Authors: | Atallah, Natalie J Panossian, Vahe S Atallah, Christine J Schwabe, Andrej Johannes, Sascha Wiemer, Jan Mansour, Michael K |
Affiliations: | Faculty of Medicine | Keywords: | COVID-19 ICU MR-proADM Biomarkers; viral pneumonia |
Issue Date: | 2022-08-24 | Part of: | Open Forum Infectious Diseases | Volume: | 9 | Issue: | 9 | Abstract: | Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider range of clinical outcomes of varying severity in patients admitted with COVID-19, and to compare to other biomarkers. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/6838 | ISSN: | 2328-8957 | DOI: | 10.1093/ofid/ofac423 | Ezproxy URL: | Link to full text | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
SCOPUSTM
Citations
2
checked on Nov 16, 2024
Record view(s)
42
checked on Nov 21, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.